The incidence of dry mouth was dose-related. XL discontinued because of adverse events. ALZA sales professionals will be dedicated to promoting the company's urology products to both urologists and high-prescribing primary care physicians. At present, overactive bladder is widely underdiagnosed and undertreated. In fact, only about 10 percent of patients with overactive bladder discuss this condition with their physician - in part because of embarrassment and the myth that overactive bladder is a normal part of aging.
Overactive bladder can have a profound impact on patients and disrupt daily routines and activities.
These individuals struggle with some of the most basic activities, such as exercising, traveling and sleeping, and may restrict social interactions with their friends and families. We encourage patients to act now and speak with their urologists or family physicians about new treatments that can help them take control and regain their them take control and regain their confidence and freedom. ALZA Corporation, headquartered in Palo Alto, Calif., is a research-based pharmaceutical company with leading drug delivery technologies. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio, and for many of the world's leading pharmaceutical companies. ALZA's sales and marketing efforts are currently focused in urology and oncology.